PTCA catheter SELUTION SLR™

coronaryballoondrug eluting

The SELUTION SLR™ Drug Eluting Balloon (DEB) is the latest generation of drug-eluting balloon technology designed to Go Beyond Metal and deliver consistent and predictable drug release as best-in-class drug-eluting stents. The New Paradigm for Coronary Interventions Breakthrough technology to deliver sustained limus release up to 90 days. CELL ADHERENT TECHNOLOGY CELL ADHERENT TECHNOLOGY (CAT)™ facilitates drug uptake and retention, in the tissue, with a minimal drug loss during the procedure while providing excellent deliverability. MICRORESERVOIRS MicroReservoirs achieve a consistent and predictable drug release, at a therapeutic level, comparable to the latest generation drug-eluting stent technology SIZE MATRIX SELUTION SLR DEB offers a broader portfolio to extend treatment options for coronary artery disease The SELUTION DeNovo Study1 A prospective randomized, multi-center, international, single-blind clinical trial comparing the SELUTION SLR DEB Strategy Versus Drug-Eluting Stent (DES) Strategy. Landmark randomized trial for coronary de-novo lesions, all-comers enrollment Designed to evaluate non-inferiority at 1 and 5 years and possible superiority at 5 years Primary Endpoints: Target Vessel Failure at 1 year and 5 years